This report is based on the findings of a November 2015-January 2016 survey exploring the views of 111 patient groups with an interest in hepatitis worldwide The report provides feedback on the corporate reputation of the pharma industry during 2015  from the perspective of these patient groups  as well as the performance of 14 pharma companies for six key indicators that influence corporate reputation